Mastering HR Summit 2011

North West Business Group30 - 31 March 2011, Frankfurt am Main, Germany.
Mastering Human Resourcing 2011 has been specifically designed to address the particular challenges current - and future - leaders face. This interactive 2 day course will be a gathering for HR executives from companies across the industries to exchange ideas, develop new partnerships and discuss the latest tools, technologies and strategies being employed in the profession to enhance departmental efficiencies and drive corporate growth.

The goal of Mastering HR 2011 is to offer valuable knowledge transfer and networking as well as to highlight future trends. We are aiming to attract all HR managers and specialists, HR service agencies, high-level personnel and line managers as well as the next generation in the profession from all over Europe.

The event will focus on the most current topics in the HR industry such as:

  • Global Diversity Management
  • Innovative HR Trends
  • ROI of Human Capital
  • Managing Different generations
  • HR Outsourcing & Insourcing
  • Recruitment Strategies
  • Managing recruitment and talentin a post-recession environment
  • Implementing change management
  • International HR strategy
  • Changing Face of HR Function
  • Engagement & Retention
  • Talent Management

Joins some of the experts like:

  • Citi, Senior Vice PresidentHR
  • Raiffeisen International, Senior Vice President HR
  • KLM, Vice President HR CIO/IS
  • The Hertz Corporation, Vice President - Global Talent Management
  • OMV, Head of human resources & orgainization
  • IBM, HR director Benelux
  • Merck Serono, Regional Director of Human Resources Middle East & Near East
  • Novonordisk, Director for performance
  • Unicredit Group, Head of coporate learning & CEO Unimangement
  • Abbott, Global HR Director
  • Royal Bank of Scotland,Director, group organisational effectiveness
  • GSMA, Director Global People Initiative
  • PepsiCo, Human ResourcesDirector Central Functions Europe
  • Group Danone, HR Director baby Nutrition
  • BT Group, MBE, HR Director
  • Astellas Pharma, Senior Director Human Resources and Facilities
  • British American Tobacco, Global Head of HR Transformation and Organization Effectiveness
  • And many more...

Who should attend?
This conference is designed to attract key decision makers from the HR industry with key job titles including: Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/ Heads, Directors, Department Heads, Managers.

For further information and registration, please visit:
http://www.nwbg.eu/all-events/master-hr-sumit-2011/

Most Popular Now

AstraZeneca amends collaboration with Ironwood for…

AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals, Inc. (Ironwood) in China mainland, China Hong Kong and China Macau for Linzess (linaclo...

Cause of antibiotic resistance identified

Scientists have confirmed for the first time that bacteria can change form to avoid being detected by antibiotics in the human body. Studying samples from elderly patient...

Bayer, Brigham and Women’s Hospital, and Massachus…

Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) today announced the launch of a joint lab to ...

FDA grants Fast Track designation for Farxiga in h…

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to reduce the risk ...

Amgen announces positive results from two Phase 3 …

Amgen (NASDAQ:AMGN) today announced that the results of a prespecified interim analysis of an open-label, randomized, controlled global multicenter Phase 3 trial (2012021...

Brilinta monotherapy in high-bleeding risk patient…

New data from TWILIGHT, a Phase IV independent trial (funded by AstraZeneca), showed that in patients at high-bleeding risk who underwent PCI and completed 3 months of du...

Gene-targeted cancer drugs, slow release overcome …

Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, prot...

Educational campaign helps teens and their caregiv…

Teenagers face many challenges, and growing up with a chronic skin disease called atopic dermatitis (AD) can impact the ups and downs and transitions to young adulthood. ...

Study points to new drug target in fight against c…

Researchers have identified a potential new drug target in the fight against cancer. In a study this week in the Proceedings of the National Academy of Sciences, an inter...

AstraZeneca divests rights for Losec to Cheplaphar…

AstraZeneca has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and associated brands to Cheplapharm Arznei...

Cheaper drug just as effective protecting heart in…

A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in...

Dengue virus becoming resistant to vaccines and th…

Researchers from Duke-NUS Medical School (DukeNUS), in collaboration with the Agency for Science, Technology and Research (A*STAR)'s Bioinformatics Institute (BII), and t...